It contains the myths related to coronavirus ,how a vaccine is developed and recently which vaccines are in phase 1 ,phase 2 and phase 3 .Furthermore ,some of the examples of covid-19 vaccine and their manufacturers are presented in the slide
Vaccine Development for COVID-19 virus, ranging from all the technologies such as DNA Vaccine, mRNA Vaccine, Whole Inactivated Vaccine, Viral Vector Vaccine. SARS-CoV-2 viral pathology is also shared in this slide.
Why is coronavirus a good biological weapon (bioweapon)?
Why is the covid-19 vaccine the ultimate endgame?
Part I of a multi-part PPT on the dangers of covid-19 vaccine.
The document discusses various types of vaccine candidates being developed for COVID-19, including inactivated vaccines, live attenuated vaccines, subunit vaccines, virus-like particles, and nucleic acid vaccines. Inactivated vaccines containing the SARS-CoV-2 spike protein have shown promise in animal models by eliciting neutralizing antibodies. Live attenuated vaccines with gene deletions have also induced immune responses while reducing pathogenicity. Subunit vaccines using the spike protein or conserved epitopes could provide broad immunity. DNA and viral vector vaccines encoding spike or nucleocapsid have similarly generated antibody and T cell responses in animal studies. Overall, the document emphasizes the importance of vaccines that stimulate both antibody and T cell immunity to provide long-lasting protection against SARS-CoV
Vaccines represent a medical intervention designed to train our defense system by administering weakened or dead versions of pathogens to warn the body so it is ready to fight if the natural version appears. Several vaccines against COVID-19 have been developed and distributed around the world in less than a year, including those using mRNA, DNA, injecting the spike protein, or a dead virus. The different vaccines have efficacy rates from 62-95% and require storage from regular refrigeration to -70°C. While side effects can include pain and fever, the vaccines effectively prevent mortality from COVID-19 and significantly reduce hospitalization.
Nature vaccine development timeline 20 major milestonesDoriaFang
The path of vaccine development over the centuries has intertwined the relentlessness of infectious disease with the great advances of science. Here we share vaccine development milestones from Nature to navigate the breakthroughs in vaccine development.
This document summarizes a symposium on COVID-19 vaccination. It provides an overview of COVID-19, statistics on cases and deaths globally and in India/Punjab. It discusses high-risk groups, signs and symptoms, vaccine development stages and approved vaccines. It also covers variants of concern, how vaccination works, reasons some may still get infected after vaccination due to factors like the Peltzman effect causing riskier behavior believing they are protected.
Vaccine Development for COVID-19 virus, ranging from all the technologies such as DNA Vaccine, mRNA Vaccine, Whole Inactivated Vaccine, Viral Vector Vaccine. SARS-CoV-2 viral pathology is also shared in this slide.
Why is coronavirus a good biological weapon (bioweapon)?
Why is the covid-19 vaccine the ultimate endgame?
Part I of a multi-part PPT on the dangers of covid-19 vaccine.
The document discusses various types of vaccine candidates being developed for COVID-19, including inactivated vaccines, live attenuated vaccines, subunit vaccines, virus-like particles, and nucleic acid vaccines. Inactivated vaccines containing the SARS-CoV-2 spike protein have shown promise in animal models by eliciting neutralizing antibodies. Live attenuated vaccines with gene deletions have also induced immune responses while reducing pathogenicity. Subunit vaccines using the spike protein or conserved epitopes could provide broad immunity. DNA and viral vector vaccines encoding spike or nucleocapsid have similarly generated antibody and T cell responses in animal studies. Overall, the document emphasizes the importance of vaccines that stimulate both antibody and T cell immunity to provide long-lasting protection against SARS-CoV
Vaccines represent a medical intervention designed to train our defense system by administering weakened or dead versions of pathogens to warn the body so it is ready to fight if the natural version appears. Several vaccines against COVID-19 have been developed and distributed around the world in less than a year, including those using mRNA, DNA, injecting the spike protein, or a dead virus. The different vaccines have efficacy rates from 62-95% and require storage from regular refrigeration to -70°C. While side effects can include pain and fever, the vaccines effectively prevent mortality from COVID-19 and significantly reduce hospitalization.
Nature vaccine development timeline 20 major milestonesDoriaFang
The path of vaccine development over the centuries has intertwined the relentlessness of infectious disease with the great advances of science. Here we share vaccine development milestones from Nature to navigate the breakthroughs in vaccine development.
This document summarizes a symposium on COVID-19 vaccination. It provides an overview of COVID-19, statistics on cases and deaths globally and in India/Punjab. It discusses high-risk groups, signs and symptoms, vaccine development stages and approved vaccines. It also covers variants of concern, how vaccination works, reasons some may still get infected after vaccination due to factors like the Peltzman effect causing riskier behavior believing they are protected.
detailed information about COVID_19 and Corona Viruses how it would be transmitted and all the preventive measures
information about the vaccine of corona virus
The document summarizes information about pharmaceutical vaccine preparation for COVID-19 in India. It discusses the different types of vaccines including inactivated, viral vector, and mRNA vaccines. It provides details on two vaccines being produced in India - Covaxin, an inactivated vaccine developed by Bharat Biotech, and Covishield, a viral vector vaccine manufactured by the Serum Institute of India under license from AstraZeneca. It also discusses the companies involved in vaccine development and production in India, as well as measures taken to ensure aseptic manufacturing conditions and the costs of the Covaxin and Covishield vaccines.
Different types of vaccines work in different ways to offer protection. But with all types of vaccines, the body is left with a supply of “memory” T-lymphocytes as well as B-lymphocytes that will remember how to fight that virus in the future.
It typically takes a few weeks after vaccination for the body to produce T-lymphocytes and B-lymphocytes.
The document discusses SARS-CoV-2 vaccines, describing how the virus infects cells, the immune response it provokes, and the different types of vaccines in development including virus, viral vector, nucleic acid and protein-based vaccines; it provides an overview of the vaccine development process and pipeline as well as the services offered by Creative Biolabs to support SARS-CoV-2 vaccine research and development.
The document discusses COVID-19 vaccines. It provides information on the types of vaccines currently in development including mRNA vaccines, protein subunit vaccines, and vector vaccines. It also discusses three vaccines currently in advanced stages of development - AZD1222, mRNA-1273, and BNT162b2. Common questions about the vaccines are addressed such as their effectiveness, potential side effects, and ability to prevent transmission.
The document summarizes information about COVID-19 mRNA vaccines, including their development, clinical trials, efficacy, safety considerations, and side effects. Some key points:
- The Pfizer/BioNTech and Moderna COVID-19 vaccines were the first mRNA vaccines approved for emergency use. Clinical trials found them to be over 94% effective with common side effects being pain, swelling at the injection site, fever, and fatigue.
- mRNA vaccines work by providing genetic instructions for cells to make the spike protein found on the COVID-19 virus, training the immune system without exposing the body to the live virus.
- Reported safety data found most side effects to be mild-to-moderate and resolve
Manufacturing the COVID-19 Pandemic Vaccine - Group 2KuchealArivalagan
The document discusses the manufacturing process for COVID-19 vaccines. It describes the traditional vaccine development process which uses weakened pathogens versus the novel mRNA vaccine process used for COVID-19 vaccines which uses genetic code to produce antigens. The manufacturing process for vaccines involves fermentation, purification, formulation, filling and packaging. Challenges in developing COVID-19 vaccines include limited worldwide distribution due to cold chain requirements, lack of long term safety and efficacy data for novel mRNA vaccines, and ensuring proper vaccine administration to stimulate immunity.
Brief report on coronavirus by incubigAnkit Lekhra
This document provides a summary of information on the novel coronavirus (COVID-19). It discusses what coronaviruses are, the symptoms of COVID-19, and details of the ongoing global research effort. Statistics on the number of cases and deaths globally are presented. The potential economic impacts are discussed, including estimates that it could cost the global economy over $1 trillion if it becomes a pandemic. The document analyzes patent filing trends related to coronavirus research and highlights the top organizations, research areas, inventors, and recent patents.
De Groot Nova Se Immunology Of Vaccines2009Annie De Groot
Brown University hosted a lecture on vaccine research and development given by Dr. Annie De Groot. The summary discusses:
1) It currently costs $200-500 million to develop a new vaccine, but the market has increased fivefold from 1990-2000 to $8 billion annually.
2) Vaccines work by training the immune system to recognize and fight infection without exposure to the pathogen. They include live attenuated, whole killed, subunit, and genetic vaccines.
3) Emerging infectious diseases since 1990 include hantavirus, ehrlichiosis, West Nile virus, SARS, and avian influenza. Preparedness for future pandemics requires vaccines for highly infectious pathogens.
Coronaviruses can cause respiratory illnesses and are transmitted between humans and other mammals. COVID-19 is caused by SARS-CoV-2, a new coronavirus that emerged in 2019 and caused a global pandemic. Approved COVID vaccines work by introducing genetic material that teaches the immune system to recognize and fight the virus. Common side effects are short-term and mean the immune system is responding as intended. Histopathological examination of COVID-19 patient lungs typically shows diffuse alveolar damage, hyaline membrane formation, and inflammation. Additional organ involvement can occur, such as acute kidney injury seen on renal histopathology.
1) The document discusses different types of COVID-19 vaccines including mRNA, inactivated, live attenuated, viral vector, and subunit vaccines. It explains how each type works to generate an immune response without causing illness.
2) Details are provided on several specific COVID-19 vaccines like Moderna, Pfizer, Covishield, Covaxin, and others in clinical trials. Information is given on dosage schedules, effectiveness, and temperature storage requirements.
3) Herd immunity through widespread vaccination is described as the safest approach, rather than intentional exposure, to prevent unnecessary illness and death while protecting populations.
- The document summarizes information on COVID-19 vaccinations, including details on approved vaccines, global vaccination rates, and the development process for vaccines. It provides data on vaccination rates in different countries and regions. It also compares the Pfizer/BioNTech, Moderna, AstraZeneca/Oxford, and Janssen vaccines, describing their approval status, dosages, efficacy rates, and side effects.
subtopic of COVID- 19 VACCINE DEVELOPMENT AND TYPESGagan Sharma
The document discusses COVID-19 vaccine development and types. It explains that vaccines work by training the immune system to recognize pathogens through immunogens like attenuated live viruses, inactivated viruses, viral proteins, or genetic material. For COVID-19, vaccines in late-stage trials use inactivated viruses, viral vectors, protein subunits, and RNA or DNA. The development process involves pre-clinical and clinical trials through phase III. As of October 2020, 10 candidates were in phase III worldwide trials to evaluate safety and efficacy.
The document discusses various COVID-19 vaccine candidates and types. It describes four main types - whole virus vaccines, protein subunit vaccines, nucleic acid vaccines, and viral vector vaccines. For each type it explains how they work, potential advantages and disadvantages, and examples of vaccines that use each approach. It provides details on some of the leading COVID-19 vaccine candidates in clinical trials, including Pfizer/BioNTech, Moderna, Oxford/AstraZeneca, and discusses the clinical trial process, recommendations for distribution, and efforts to scale up production and distribution of approved vaccines.
COVID-19 Vaccines, The Biological Weapons of Mass Destruction, by Igor Shephe...Guy Boulianne
This document discusses the potential use of vaccines and genetic engineering techniques to develop biological weapons. It describes how vaccines could be used to weaken a population's immunity before a secondary biological attack. It also outlines how genetic engineering of pathogens could make them more resistant, toxic, stable and virulent. Projects from Soviet-era bioweapons programs, like Obolensk and Vector, are cited as pursuing techniques like modifying viruses with toxin genes or creating antibiotic-resistant strains. The goals of such research are said to include increasing a pathogen's pathogenicity and creating novel strains with new dangerous properties.
There are four main types of COVID-19 vaccines: viral vector vaccines like AstraZeneca, genetic vaccines like Moderna and Pfizer, inactivated vaccines like Sinovac, and protein-based vaccines like Novavax. Viral vector and genetic vaccines work by introducing genetic material that causes cells to produce viral proteins to stimulate an immune response. Inactivated vaccines contain killed virus to trigger immunity. Protein vaccines contain synthesized spike proteins to teach the immune system to recognize the virus. Common side effects include pain at the injection site, tiredness, and fever.
Vaccines are biological preparations that improve immunity to particular diseases. They work by containing an agent that resembles a disease-causing microorganism, which stimulates the immune system to recognize and destroy it. Vaccination is the most effective method of preventing infectious diseases and has been largely responsible for eradicating smallpox and restricting diseases like polio. There are several types of vaccines including live attenuated, inactivated, subunit, toxoid, conjugate, DNA, and recombinant vector vaccines. Vaccines must undergo clinical trials and require careful storage and transport to maintain effectiveness.
Pfizer GET THE FACTS ON OUR COVID-19 VACCINE CANDIDATESSrinivasaReddy137
Pfizer and BioNTech announced dosing the first participants in the U.S. with their experimental mRNA COVID-19 vaccine. Vaccines work by stimulating the immune system to produce antibodies to prevent disease without having to get the disease first. Pfizer and BioNTech are focusing on an mRNA technology that provides genetic instructions for cells to produce viral proteins to stimulate antibody production. They have selected four experimental mRNA vaccine candidates based on pre-clinical studies indicating potential safety and effectiveness against COVID-19.
A COVID 19 vaccine is a vaccine intended to provide acquired immunity against severe acute respiratory syndrome coronavirus 2 (SARS CoV 2), the virus causing coronavirus disease 2019 (COVID 19). types of active and inactivated vaccine
Vaccines are developed through a long process involving research, clinical trials, and regulatory approval. The development process typically takes 10-15 years and costs $100-700 million. Vaccines go through pre-clinical testing in animals followed by four phases of clinical trials in humans to demonstrate safety, immunogenicity, efficacy, and effectiveness. Disease burden studies are important for prioritizing the development of new vaccines and determining vaccination policies and target groups. Vaccines have led to major public health achievements by reducing morbidity and mortality from many infectious diseases.
Covid 19, vaccine and it's development process - Group 1XinLu53
The document summarizes COVID-19, the development of vaccines for COVID-19, and compares the traditional vaccine development process to the COVID-19 vaccine development process. Specifically:
1) It provides background on COVID-19, describing the virus, symptoms, and transmission routes.
2) It discusses the global effort to develop COVID-19 vaccines, with over 157 candidates in development as of June 2020 and 16 in clinical trials.
3) It summarizes the AstraZeneca/Oxford AZD1222 vaccine, how it works, and results from Phase 1/2 clinical trials showing an immune response.
4) It compares the traditional long vaccine development process, taking 6-20 years, to the accelerated
detailed information about COVID_19 and Corona Viruses how it would be transmitted and all the preventive measures
information about the vaccine of corona virus
The document summarizes information about pharmaceutical vaccine preparation for COVID-19 in India. It discusses the different types of vaccines including inactivated, viral vector, and mRNA vaccines. It provides details on two vaccines being produced in India - Covaxin, an inactivated vaccine developed by Bharat Biotech, and Covishield, a viral vector vaccine manufactured by the Serum Institute of India under license from AstraZeneca. It also discusses the companies involved in vaccine development and production in India, as well as measures taken to ensure aseptic manufacturing conditions and the costs of the Covaxin and Covishield vaccines.
Different types of vaccines work in different ways to offer protection. But with all types of vaccines, the body is left with a supply of “memory” T-lymphocytes as well as B-lymphocytes that will remember how to fight that virus in the future.
It typically takes a few weeks after vaccination for the body to produce T-lymphocytes and B-lymphocytes.
The document discusses SARS-CoV-2 vaccines, describing how the virus infects cells, the immune response it provokes, and the different types of vaccines in development including virus, viral vector, nucleic acid and protein-based vaccines; it provides an overview of the vaccine development process and pipeline as well as the services offered by Creative Biolabs to support SARS-CoV-2 vaccine research and development.
The document discusses COVID-19 vaccines. It provides information on the types of vaccines currently in development including mRNA vaccines, protein subunit vaccines, and vector vaccines. It also discusses three vaccines currently in advanced stages of development - AZD1222, mRNA-1273, and BNT162b2. Common questions about the vaccines are addressed such as their effectiveness, potential side effects, and ability to prevent transmission.
The document summarizes information about COVID-19 mRNA vaccines, including their development, clinical trials, efficacy, safety considerations, and side effects. Some key points:
- The Pfizer/BioNTech and Moderna COVID-19 vaccines were the first mRNA vaccines approved for emergency use. Clinical trials found them to be over 94% effective with common side effects being pain, swelling at the injection site, fever, and fatigue.
- mRNA vaccines work by providing genetic instructions for cells to make the spike protein found on the COVID-19 virus, training the immune system without exposing the body to the live virus.
- Reported safety data found most side effects to be mild-to-moderate and resolve
Manufacturing the COVID-19 Pandemic Vaccine - Group 2KuchealArivalagan
The document discusses the manufacturing process for COVID-19 vaccines. It describes the traditional vaccine development process which uses weakened pathogens versus the novel mRNA vaccine process used for COVID-19 vaccines which uses genetic code to produce antigens. The manufacturing process for vaccines involves fermentation, purification, formulation, filling and packaging. Challenges in developing COVID-19 vaccines include limited worldwide distribution due to cold chain requirements, lack of long term safety and efficacy data for novel mRNA vaccines, and ensuring proper vaccine administration to stimulate immunity.
Brief report on coronavirus by incubigAnkit Lekhra
This document provides a summary of information on the novel coronavirus (COVID-19). It discusses what coronaviruses are, the symptoms of COVID-19, and details of the ongoing global research effort. Statistics on the number of cases and deaths globally are presented. The potential economic impacts are discussed, including estimates that it could cost the global economy over $1 trillion if it becomes a pandemic. The document analyzes patent filing trends related to coronavirus research and highlights the top organizations, research areas, inventors, and recent patents.
De Groot Nova Se Immunology Of Vaccines2009Annie De Groot
Brown University hosted a lecture on vaccine research and development given by Dr. Annie De Groot. The summary discusses:
1) It currently costs $200-500 million to develop a new vaccine, but the market has increased fivefold from 1990-2000 to $8 billion annually.
2) Vaccines work by training the immune system to recognize and fight infection without exposure to the pathogen. They include live attenuated, whole killed, subunit, and genetic vaccines.
3) Emerging infectious diseases since 1990 include hantavirus, ehrlichiosis, West Nile virus, SARS, and avian influenza. Preparedness for future pandemics requires vaccines for highly infectious pathogens.
Coronaviruses can cause respiratory illnesses and are transmitted between humans and other mammals. COVID-19 is caused by SARS-CoV-2, a new coronavirus that emerged in 2019 and caused a global pandemic. Approved COVID vaccines work by introducing genetic material that teaches the immune system to recognize and fight the virus. Common side effects are short-term and mean the immune system is responding as intended. Histopathological examination of COVID-19 patient lungs typically shows diffuse alveolar damage, hyaline membrane formation, and inflammation. Additional organ involvement can occur, such as acute kidney injury seen on renal histopathology.
1) The document discusses different types of COVID-19 vaccines including mRNA, inactivated, live attenuated, viral vector, and subunit vaccines. It explains how each type works to generate an immune response without causing illness.
2) Details are provided on several specific COVID-19 vaccines like Moderna, Pfizer, Covishield, Covaxin, and others in clinical trials. Information is given on dosage schedules, effectiveness, and temperature storage requirements.
3) Herd immunity through widespread vaccination is described as the safest approach, rather than intentional exposure, to prevent unnecessary illness and death while protecting populations.
- The document summarizes information on COVID-19 vaccinations, including details on approved vaccines, global vaccination rates, and the development process for vaccines. It provides data on vaccination rates in different countries and regions. It also compares the Pfizer/BioNTech, Moderna, AstraZeneca/Oxford, and Janssen vaccines, describing their approval status, dosages, efficacy rates, and side effects.
subtopic of COVID- 19 VACCINE DEVELOPMENT AND TYPESGagan Sharma
The document discusses COVID-19 vaccine development and types. It explains that vaccines work by training the immune system to recognize pathogens through immunogens like attenuated live viruses, inactivated viruses, viral proteins, or genetic material. For COVID-19, vaccines in late-stage trials use inactivated viruses, viral vectors, protein subunits, and RNA or DNA. The development process involves pre-clinical and clinical trials through phase III. As of October 2020, 10 candidates were in phase III worldwide trials to evaluate safety and efficacy.
The document discusses various COVID-19 vaccine candidates and types. It describes four main types - whole virus vaccines, protein subunit vaccines, nucleic acid vaccines, and viral vector vaccines. For each type it explains how they work, potential advantages and disadvantages, and examples of vaccines that use each approach. It provides details on some of the leading COVID-19 vaccine candidates in clinical trials, including Pfizer/BioNTech, Moderna, Oxford/AstraZeneca, and discusses the clinical trial process, recommendations for distribution, and efforts to scale up production and distribution of approved vaccines.
COVID-19 Vaccines, The Biological Weapons of Mass Destruction, by Igor Shephe...Guy Boulianne
This document discusses the potential use of vaccines and genetic engineering techniques to develop biological weapons. It describes how vaccines could be used to weaken a population's immunity before a secondary biological attack. It also outlines how genetic engineering of pathogens could make them more resistant, toxic, stable and virulent. Projects from Soviet-era bioweapons programs, like Obolensk and Vector, are cited as pursuing techniques like modifying viruses with toxin genes or creating antibiotic-resistant strains. The goals of such research are said to include increasing a pathogen's pathogenicity and creating novel strains with new dangerous properties.
There are four main types of COVID-19 vaccines: viral vector vaccines like AstraZeneca, genetic vaccines like Moderna and Pfizer, inactivated vaccines like Sinovac, and protein-based vaccines like Novavax. Viral vector and genetic vaccines work by introducing genetic material that causes cells to produce viral proteins to stimulate an immune response. Inactivated vaccines contain killed virus to trigger immunity. Protein vaccines contain synthesized spike proteins to teach the immune system to recognize the virus. Common side effects include pain at the injection site, tiredness, and fever.
Vaccines are biological preparations that improve immunity to particular diseases. They work by containing an agent that resembles a disease-causing microorganism, which stimulates the immune system to recognize and destroy it. Vaccination is the most effective method of preventing infectious diseases and has been largely responsible for eradicating smallpox and restricting diseases like polio. There are several types of vaccines including live attenuated, inactivated, subunit, toxoid, conjugate, DNA, and recombinant vector vaccines. Vaccines must undergo clinical trials and require careful storage and transport to maintain effectiveness.
Pfizer GET THE FACTS ON OUR COVID-19 VACCINE CANDIDATESSrinivasaReddy137
Pfizer and BioNTech announced dosing the first participants in the U.S. with their experimental mRNA COVID-19 vaccine. Vaccines work by stimulating the immune system to produce antibodies to prevent disease without having to get the disease first. Pfizer and BioNTech are focusing on an mRNA technology that provides genetic instructions for cells to produce viral proteins to stimulate antibody production. They have selected four experimental mRNA vaccine candidates based on pre-clinical studies indicating potential safety and effectiveness against COVID-19.
A COVID 19 vaccine is a vaccine intended to provide acquired immunity against severe acute respiratory syndrome coronavirus 2 (SARS CoV 2), the virus causing coronavirus disease 2019 (COVID 19). types of active and inactivated vaccine
Vaccines are developed through a long process involving research, clinical trials, and regulatory approval. The development process typically takes 10-15 years and costs $100-700 million. Vaccines go through pre-clinical testing in animals followed by four phases of clinical trials in humans to demonstrate safety, immunogenicity, efficacy, and effectiveness. Disease burden studies are important for prioritizing the development of new vaccines and determining vaccination policies and target groups. Vaccines have led to major public health achievements by reducing morbidity and mortality from many infectious diseases.
Covid 19, vaccine and it's development process - Group 1XinLu53
The document summarizes COVID-19, the development of vaccines for COVID-19, and compares the traditional vaccine development process to the COVID-19 vaccine development process. Specifically:
1) It provides background on COVID-19, describing the virus, symptoms, and transmission routes.
2) It discusses the global effort to develop COVID-19 vaccines, with over 157 candidates in development as of June 2020 and 16 in clinical trials.
3) It summarizes the AstraZeneca/Oxford AZD1222 vaccine, how it works, and results from Phase 1/2 clinical trials showing an immune response.
4) It compares the traditional long vaccine development process, taking 6-20 years, to the accelerated
COVID-19 is a respiratory illness caused by a novel coronavirus (SARS-CoV-2) that emerged in Wuhan, China in late 2019. Symptoms include fever, dry cough, and shortness of breath. The incubation period is up to 14 days. The virus spread rapidly globally within 3 months, infecting over 29 million people worldwide by April 2020. On March 11, 2020, the WHO declared COVID-19 a pandemic due to its worldwide spread and severe health impacts, especially on the elderly and those with preexisting conditions. The pandemic has caused major economic impacts including a projected 4% contraction of global GDP in 2020 and the loss of 225 million full-time jobs.
This teaching plan provides preventive measures for COVID-19 tailored for students with ADHD. It outlines objectives to increase knowledge of COVID-19 origins and transmission, encourage application of preventive behaviors, and demonstrate proper hygiene practices. The content review defines COVID-19, discusses symptoms and health impacts, and explains preventive actions like handwashing, physical distancing, mask wearing, and vaccinations. Methods include presentations, discussions, and demonstrations to engage students cognitively, affectively, and psychomotor skills. Evaluation involves paper tests to assess learning and skill application.
CEPI's 100 DAYS AMBITION - HOW DO WE DEVELOP A VACCINE IN 100 DAYSiQHub
CEPI's 100 Days Mission aims to develop a vaccine within 100 days from when a pathogen is sequenced or the need for a vaccine is recognized to initial availability. This would have allowed for vaccines to be available months earlier in the COVID-19 pandemic. CEPI is pursuing several strategies to achieve this goal, including developing prototype vaccine libraries for multiple virus families, building more distributed global manufacturing capacity, and rethinking clinical trial and regulatory approaches to allow for more real-world evidence collection in emergencies. The goal is extremely ambitious but CEPI believes that with vision and collaboration, significant improvements in response time are possible.
Impact of Covid19 Knowledge, Attitude and Practice KAP in Food Industry, Indiaijtsrd
COVID 19 coronavirus is one of the highly infectious and transmittable disease caused by SARS COV 2 that human era has ever faced. At the end of December 2019, novel virus named COVID 19 emerged in large seafood market at Wuhan china, causing respiratory infections thereby death cases is numerically increasing in lakh due to rapid transmission of virus. Background Global covid 19 pandemic generate a pressing need to upgrade food establishments with standard Food safety protocols which are required to keep their premises safe for their guests and customers. Objectives The objective of the study is to assess the knowledge, awareness and practice among food handlers. Methodology A voluntary online survey was conducted among food handlers working in different food outlets and star hotels in TamilNadu, India. A questionnaire was structured and mailed to the participants. Results A total of 53 responses have been recorded. In which ninety seven percentage respondents are male and three percentage of respondents are female. Ninety three percent of the respondents are aware that hand dryers are not effective in killing coronavirus. Eighty five percent of respondents strongly agreed to the statement of educating patients, household members and caregivers about covid 19. Conclusion The results of this study show that, majority of the food handlers has excellent knowledge, hygienic practice and awareness of covid 19. Ms. J. Suja Kannu | Ms. J. Vinodha Evangeline | K. Karthick "Impact of Covid19: Knowledge, Attitude and Practice (KAP) in Food Industry, India" Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-4 | Issue-4 , June 2020, URL: https://www.ijtsrd.com/papers/ijtsrd31649.pdf Paper Url :https://www.ijtsrd.com/home-science/health-and-hygiene/31649/impact-of-covid19-knowledge-attitude-and-practice-kap-in-food-industry-india/ms-j-suja-kannu
The document discusses several common myths and facts about the COVID-19 vaccine. It addresses myths such as the vaccine being unsafe because it was developed quickly, that it will alter DNA or contain tracking devices. It also discusses facts such as the vaccine undergoing the same rigorous approval process and that side effects are typically mild. While the vaccine may not prevent all infections, it can provide protection and help reduce the spread of the virus.
This document provides an overview of vaccination programs and implementation. It discusses vaccine-preventable diseases, types of vaccines, routes of administration, levels of effectiveness, and the history of vaccination programs in India. Key points include: immunization aims to prevent or eradicate diseases; common vaccine-preventable diseases include diphtheria, measles, and polio; vaccines can be live, attenuated, inactivated, or toxoids; and India's vaccination efforts began in the early 1800s with smallpox vaccination and expanded in the late 20th century with the Universal Immunisation Programme.
Natural Approach Targeting Gut Dysbiosis - Hipersensitivity - Inflammation Tr...asistenvirtual
This document discusses natural approaches for targeting the gut dysbiosis-hypersensitivity-inflammation triad in COVID-19. It covers the gut microbiome and its role in health. Probiotics, prebiotics, symbiotics, healthy diet and herbs are proposed as opportunities to impact the triad and focus on gut health as preventive approaches for COVID-19. Clinical trials studying the gut microbiota in COVID-19 patients are also discussed. The document examines lessons from China on herbal medicine and TCM influence on the gut microbiota. Current work in Indonesia on formulating symbiotic supplements combining probiotics and indigenous herbs is mentioned.
The era of instantaneous pathogen detection is finally here. Opteev's Multiplex Biosensor is able to detect and identify any pathogen in just 60 seconds with over 99% accuracy, allowing for the first truly comprehensive multiplex diagnostics at the Point-of-Care while revolutionizing environmental monitoring, food safety, at at-home testing. Witness the unmatched speed, precision, and accessibility of Opteev's Multiplex Biosensor. Witness the dawn of a new era.
Background:
COVID-19 vaccine, the world is expecting it early because the rate of infection across the world is much higher than expected. India is the second-worst affected country hit by the epidemic, with over 1. 2 million cases. The virus spreading rapidly and to the majority of the world's population is susceptible for it. The scientists and medical researchers all around the world are working relentlessly for the development of a safe and effective vaccine. Thanks to the COVID-19 warriors & entire medical researchers and scientists for their involvement towards the humanity.
What is Vaccine:
A vaccine is a biological preparation that provides active acquired immunity to a particular infectious disease. a vaccine is a preparation that helps to protect against certain diseases. vaccines contain a dead or weakened form of a microbe. Vaccination is a simple, safe, and effective method of protecting people against risky diseases, before they come into contact with them.
This document discusses biological weapons and bioterrorism. It defines biological weapons and lists ideal characteristics. It describes epidemiological clues to detecting a biological attack and biosafety levels. It focuses on smallpox, anthrax, plague, and botulism as potential biological weapons and summarizes detection, treatment, prophylaxis, and response in the event of a biological attack.
A presentation on my life in public health and vaccinations- from measles in the West Midlands of England, 1983-2014 to COVID-19 in Europe, 2020-now, implications for the public health community and vaccines manufactures including the vaccine TRIPS waiver. Presentation to a Spanish public health and vaccines forum, October 18th 2021 211018 middleton spanish vaccines and industry presentation 1 version recorded
This document discusses universal masking in hospitals during the COVID-19 pandemic. While masks provide little protection outside healthcare settings, they may offer benefits within hospitals. First, masks are important personal protective equipment for healthcare workers interacting with symptomatic patients. Additionally, masks may help reduce transmission from asymptomatic or mildly symptomatic healthcare workers to other staff and patients. However, masks alone provide only slight protection if the eyes are exposed or the mask is touched. Universal masking policies in hospitals aim to reduce transmission, but may give a false sense of security and increase face touching. The greatest impact may be reducing anxiety.
Role of chemical engineers to combat COVID 19 PandemicSABARINATH C D
Role of chemical engineer to combat COVID 19 Pandemic:
COVID-19,it is a disease caused by the SARS-CoV-2 virus. It was identified in December
2019 at Wuhan in China. On 11 March 2020 World Health Organization declared that it is a
global pandemic. Millions of people disrupted by this infectious respiratory disease outbreak.
All professionals are contributing to reduce this pandemic .as well as chemical engineering
professionals respond to this scenario. From the development of smaller, faster computer
chips to innovations in recycling, treating diseases, water treatment, and generating energy,
the processes and products that chemical engineers have helped to create a better world
.There are lot of great achievements, bold innovators, and new frontiers in the fields of
energy, the environment, biomedicine, electronics, food production, and materials from the
world of chemical engineering. So the chemical engineers are joining to respond to the
COVID-19 challenges. They can contribute more to help society through this pandemic.
Current Status and Future Perspective of Rapid Diagnostic Kits Vaccine agains...ijtsrd
Coronavirus disease 2019 COVID 19 , which causes serious respiratory illness such as pneumonia and lung failure, was first reported in Wuhan, the capital of Hubei, China. The etiological agent of COVID 19 has been confirmed as a novel coronavirus, now known as severe acute respiratory syndrome coronavirus 2 SARS CoV 2 , which is most likely originated from zoonotic coronaviruses, like SARS CoV, which emerged in 2002. Rapid diagnostics, vaccines and therapeutics are important interventions for the management of the 2019 novel coronavirus 2019 nCoV outbreak. Currently, various diagnostic kits to test for COVID 19 are available and several repurposing therapeutics for COVID 19 have shown to be clinically effective. In addition, global institutions and companies have begun to develop vaccines for the prevention of COVID 19. Here, we review the current status of, diagnosis, and vaccine development for COVID 19. M A Nandedkar | R A Shinde | S S Bansode "Current Status and Future Perspective of Rapid Diagnostic Kits / Vaccine against COVID-19" Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-4 | Issue-4 , June 2020, URL: https://www.ijtsrd.com/papers/ijtsrd30977.pdf Paper Url :https://www.ijtsrd.com/pharmacy/analytical-chemistry/30977/current-status-and-future-perspective-of-rapid-diagnostic-kits--vaccine-against-covid19/m-a-nandedkar
Coronaviruses are a large family of viruses that can transmit between animals and humans. COVID-19 is caused by the SARS-CoV-2 virus, which likely originated in bats. Common symptoms include fever, cough and loss of taste/smell, while serious symptoms include difficulty breathing. Infections are diagnosed via tests of nasal/throat swabs. Treatments include antiviral medications like Paxlovid, Remdesivir and Molnupiravir. Prevention methods include vaccination, mask-wearing, distancing and hand hygiene.
The document provides information about COVID-19 vaccines in India. It discusses two main vaccines approved for use - Covishield and Covaxin. Covishield is the local version of the Oxford-AstraZeneca vaccine manufactured by the Serum Institute of India. Covaxin is Bharat Biotech's indigenous vaccine developed in collaboration with ICMR. Both vaccines received emergency use approval from the Drugs Controller General of India. The document also provides details on vaccine efficacy, dosing schedules, manufacturing companies, approval process, vaccination coverage trends in India, and strategies to build confidence in COVID-19 vaccines.
This particular slides consist of- what is Pneumothorax,what are it's causes and it's effect on body, risk factors, symptoms,complications, diagnosis and role of physiotherapy in it.
This slide is very helpful for physiotherapy students and also for other medical and healthcare students.
Here is a summary of Pneumothorax:
Pneumothorax, also known as a collapsed lung, is a condition that occurs when air leaks into the space between the lung and chest wall. This air buildup puts pressure on the lung, preventing it from expanding fully when you breathe. A pneumothorax can cause a complete or partial collapse of the lung.
Michigan HealthTech Market Map 2024. Includes 7 categories: Policy Makers, Academic Innovation Centers, Digital Health Providers, Healthcare Providers, Payers / Insurance, Device Companies, Life Science Companies, Innovation Accelerators. Developed by the Michigan-Israel Business Accelerator
Chandrima Spa Ajman is one of the leading Massage Center in Ajman, which is open 24 hours exclusively for men. Being one of the most affordable Spa in Ajman, we offer Body to Body massage, Kerala Massage, Malayali Massage, Indian Massage, Pakistani Massage Russian massage, Thai massage, Swedish massage, Hot Stone Massage, Deep Tissue Massage, and many more. Indulge in the ultimate massage experience and book your appointment today. We are confident that you will leave our Massage spa feeling refreshed, rejuvenated, and ready to take on the world.
Visit : https://massagespaajman.com/
Call : 052 987 1315
Can Allopathy and Homeopathy Be Used Together in India.pdfDharma Homoeopathy
This article explores the potential for combining allopathy and homeopathy in India, examining the benefits, challenges, and the emerging field of integrative medicine.
Under Pressure : Kenneth Kruk's StrategyKenneth Kruk
Kenneth Kruk's story of transforming challenges into opportunities by leading successful medical record transitions and bridging scientific knowledge gaps during COVID-19.
Unlocking the Secrets to Safe Patient Handling.pdfLift Ability
Furthermore, the time constraints and workload in healthcare settings can make it challenging for caregivers to prioritise safe patient handling Australia practices, leading to shortcuts and increased risks.
Hypertension and it's role of physiotherapy in it.Vishal kr Thakur
This particular slides consist of- what is hypertension,what are it's causes and it's effect on body, risk factors, symptoms,complications, diagnosis and role of physiotherapy in it.
This slide is very helpful for physiotherapy students and also for other medical and healthcare students.
Here is summary of hypertension -
Hypertension, also known as high blood pressure, is a serious medical condition that occurs when blood pressure in the body's arteries is consistently too high. Blood pressure is the force of blood pushing against the walls of blood vessels as the heart pumps it. Hypertension can increase the risk of heart disease, brain disease, kidney disease, and premature death.
Healthy Eating Habits:
Understanding Nutrition Labels: Teaches how to read and interpret food labels, focusing on serving sizes, calorie intake, and nutrients to limit or include.
Tips for Healthy Eating: Offers practical advice such as incorporating a variety of foods, practicing moderation, staying hydrated, and eating mindfully.
Benefits of Regular Exercise:
Physical Benefits: Discusses how exercise aids in weight management, muscle and bone health, cardiovascular health, and flexibility.
Mental Benefits: Explains the psychological advantages, including stress reduction, improved mood, and better sleep.
Tips for Staying Active:
Encourages consistency, variety in exercises, setting realistic goals, and finding enjoyable activities to maintain motivation.
Maintaining a Balanced Lifestyle:
Integrating Nutrition and Exercise: Suggests meal planning and incorporating physical activity into daily routines.
Monitoring Progress: Recommends tracking food intake and exercise, regular health check-ups, and provides tips for achieving balance, such as getting sufficient sleep, managing stress, and staying socially active.
Dr. David Greene R3 stem cell Breakthroughs: Stem Cell Therapy in CardiologyR3 Stem Cell
Dr. David Greene, founder and CEO of R3 Stem Cell, is at the forefront of groundbreaking research in the field of cardiology, focusing on the transformative potential of stem cell therapy. His latest work emphasizes innovative approaches to treating heart disease, aiming to repair damaged heart tissue and improve heart function through the use of advanced stem cell techniques. This research promises not only to enhance the quality of life for patients with chronic heart conditions but also to pave the way for new, more effective treatments. Dr. Greene's work is notable for its focus on safety, efficacy, and the potential to significantly reduce the need for invasive surgeries and long-term medication, positioning stem cell therapy as a key player in the future of cardiac care.
This particular slides consist of- what is hypotension,what are it's causes and it's effect on body, risk factors, symptoms,complications, diagnosis and role of physiotherapy in it.
This slide is very helpful for physiotherapy students and also for other medical and healthcare students.
Here is the summary of hypotension:
Hypotension, or low blood pressure, is when the pressure of blood circulating in the body is lower than normal or expected. It's only a problem if it negatively impacts the body and causes symptoms. Normal blood pressure is usually between 90/60 mmHg and 120/80 mmHg, but pressures below 90/60 are generally considered hypotensive.
PET CT beginners Guide covers some of the underrepresented topics in PET CTMiadAlsulami
This lecture briefly covers some of the underrepresented topics in Molecular imaging with cases , such as:
- Primary pleural tumors and pleural metastases.
- Distinguishing between MPM and Talc Pleurodesis.
- Urological tumors.
- The role of FDG PET in NET.
Can coffee help me lose weight? Yes, 25,422 users in the USA use it for that ...nirahealhty
The South Beach Coffee Java Diet is a variation of the popular South Beach Diet, which was developed by cardiologist Dr. Arthur Agatston. The original South Beach Diet focuses on consuming lean proteins, healthy fats, and low-glycemic index carbohydrates. The South Beach Coffee Java Diet adds the element of coffee, specifically caffeine, to enhance weight loss and improve energy levels.
2. Myth
Sun Exposure kills Coronavirus
Myth
Being able to hold your breath for
10 seconds or more without
coughing or feeling discomfort
means you are free from COVID-
19
(“Mythbusters,” 2020)
3. Myth
The prolonged use of medical
masks* when properly worn, DOES
cause CO2 intoxication and oxygen
deficiency
Myth
Rinsing your nose with saline does
prevent COVID-19
(“Mythbusters,” 2020)
4. Vaccine development
Sample secured
and replication of
virus
Replication of
virus
Characterization
of virus
Bioinformatics and
sequencing of the virus
to understand changes
Host
response to
infection
Development
of biological
model
Quantification of
vaccine efficacy
Challenge of
biological models
with the virus
Vaccination of
biological models
Preclinical
test of vaccine
for efficacy
Phase 1:Human
trials involving a
small number of
healthy volunteers
,tests the vaccine
for safety
Phase 3 human trials
involving several thousand
people ,looks at how
effective the vaccine is.
General release
administration
Large scale
manufactur
e of vaccine
Phase 2 human
trials involving several
hundred people
,usually in an affected
area,looks at how
effective the vaccine is
Scaled up
production
of vaccine
(Ranasinghe Kashmi and Vasan S.S, 2020)